The EHA Research Roadmap: Malignant Lymphoid Diseases

• Martin Dreyling,
• Marc André,
• Nicola Gökbuget,
• Hervé Tilly,
• Mats Jerkeman,
• John Gribben,
• Andrés Ferreri,
• Pierre Morel,
• Stephan Stilgenbauer,
• Christopher Fox,
• José Maria Ribera,
• Sonja Zweegman,
• Igor Aurer,
• Csaba Bödör,
• Birgit Burkhardt,
• Christian Buske,
• Maria Dollores Caballero,
• Elias Campo,
• Bjoern Chapuy,
• Andrew Davies,
• Laurence de Leval,
• Jeanette Doorduijn,
• Massimo Federico,
• Philippe Gaulard,
• Francesca Gay,
• Paolo Ghia,
• Kirsten Grønbæk,
• Hartmut Goldschmidt,
• Marie-Jose Kersten,
• Barbara Kiesewetter,
• Judith Landman-Parker,
• Steven Le Gouill,
• Georg Lenz,
• Sirpa Leppä,
• Armando Lopez-Guillermo,
• Elizabeth Macintyre,
• Maria Victoria Mateos Mantega,
• Philippe Moreau,
• Carol Moreno,
• Bertrand Nadel,
• Jessica Okosun,
• Roger Owen,
• Sarka Pospisilova,
• Christiane Pott,
• Tadeusz Robak,
• Michelle Spina,
• Kostas Stamatopoulos,
• Jan Stary,
• Karin Tarte,
• Allessandra Tedeschi,
• Catherine Thieblemont,
• Ralf Ulrich Trappe,
• Lorenz H. Trümper,
• Gilles Salles

Affiliations

Martin Dreyling

1 Department of Medicine III, LMU Hospital, Munich, Germany

Marc André

2 Université Catholique de Louvain, CHU UcL Namur, Yvoir, Belgium

Nicola Gökbuget

3 Department of Medicine II, Hematology/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany

Hervé Tilly

4 INSERM U1245, Department of Hematology, Centre Henri Becquerel and Université de Rouen, France

Mats Jerkeman

5 Skåne University and Lund University, Lund, Sweden

John Gribben

6 Barts Cancer Institute, Queen Mary University of London, United Kingdom

Andrés Ferreri

7 Lymphoma Unit, Department of Onco-hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy

Pierre Morel

8 Service Hematologie Clinique Therapie Cellulaire, CHU Amiens Picardie, Amiens, France

Stephan Stilgenbauer

9 Comprehensive Cancer Center Ulm (CCCU), Sektion CLL Klinik für Innere Medizin III, Universität Ulm, Germany

Christopher Fox

10 School of Medicine, University of Nottingham, United Kingdom

José Maria Ribera

11 Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Badalona, Spain

Sonja Zweegman

12 Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands

Igor Aurer

13 University Hospital Centre Zagreb and Medical School, University of Zagreb, Croatia

Csaba Bödör

14 HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary

Birgit Burkhardt

15 Experimentelle und Translationale päd. Hämatologie u Onkologie, Leitung der Bereiche Lymphome und Stammzelltransplantation, Universitätsklinikum Münster (UKM), Klinik für Kinder- und Jugendmedizin, Pädiatrische Hämatologie und Onkologie, Munich, Germany

Christian Buske

16 Institute of Experimental Cancer Research, CCC Ulm, University Hospital Ulm, Germany

Maria Dollores Caballero

17 Clinical and Transplant Unit, University Hospital of Salamanca, Spain

Elias Campo

20 Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

Bjoern Chapuy

21 Department of Hematology, Oncology and Tumor Immunology, Charité, University Medical Center Berlin, Campus Benjamin Franklin, Berlin, Germany

Andrew Davies

23 Southampton NCRI/UK Experimental Cancer Medicines Centre, Faculty of Medicine, University of Southampton, United Kingdom

Laurence de Leval

24 Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland

Jeanette Doorduijn

25 Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands

Massimo Federico

26 Città di Lecce Hospital, GVM Care & Research, Lecce, Italy

Philippe Gaulard

27 Département de Pathologie, Hôpital Henri Mondor, AP-HP, Créteil, France

Francesca Gay

28 Clinical Trial Unit, Division of Hematology 1, AOU Città Della Salute e Della Scienza, University of Torino, Italy

Paolo Ghia

29 Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy

Kirsten Grønbæk

30 Department of Hematology, Rigshospitalet, Copenhagen, Denmark

Hartmut Goldschmidt

32 University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany

Marie-Jose Kersten

33 Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and LYMMCARE, Amsterdam, the Netherlands

Barbara Kiesewetter

34 Department of Medicine I, Division of Oncology, Medical University of Vienna, Austria

Judith Landman-Parker

35 Pediatric Hematology Oncology, Sorbonne Université APHP/hôpital A Trousseau, Paris, France

Steven Le Gouill

36 Service d’Hématologie, Clinique du Centre Hospitalier Universitaire (CHU) de Nantes, France

Georg Lenz

37 Medical Department A for Hematology, Oncology and Pneumology, University Hospital Münster, Germany

Sirpa Leppä

38 University of Helsinki and Helsinki University Hospital Comprehensive Cancer Centre, Helsinki, Finland

Armando Lopez-Guillermo

39 Department of Hematology, Hospital Clínic de Barcelona, Spain

Elizabeth Macintyre

40 Onco-hematology, Université de Paris and Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, France

Maria Victoria Mateos Mantega

41 Complejo Asistencial Universitario de Salamanca, IBSAL, CIC, Universidad de Salamanca, Ciberonc, Salamanca, Spain

Philippe Moreau

42 Hematology Department, University Hospital Hotel-Dieu, Nantes, France

Carol Moreno

43 Hospital de la Santa Creu I Sant Pau, Autonomous University of Barcelona, Spain

Bertrand Nadel

44 Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France

Jessica Okosun

45 Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, United Kingdom

Roger Owen

46 St James’s Institute of Oncology, Leeds, United Kingdom

Sarka Pospisilova

47 Department of Internal Medicine—Hematology and Oncology and Department of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University and University Hospital Brno, Czech Republic

Christiane Pott

48 Klinisch-experimentelle Hämatologie, Medizinische Klinik II, Hämatologie und Internistische Onkologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Germany

Tadeusz Robak

49 Medical University of Lodz, Poland

Michelle Spina

50 Division of Medical Oncology and Immune-related Tumors, National Cancer Institute, Aviano, Italy

Kostas Stamatopoulos

51 Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece

Jan Stary

52 Department of Pediatric Hematology and Oncology 2nd Faculty of Medicine, Charles University Prague University Hospital, Prague, Czech Republic

Karin Tarte

53 Immunology and Cell Therapy Lab at Rennes University Hospital, Rennes, France

Allessandra Tedeschi

54 Department of Hematology, Niguarda Hospital Milano, Italy

Catherine Thieblemont

55 Department of Hemato-Oncology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France

Ralf Ulrich Trappe

56 Department of Internal Medicine II: Haematology and Oncology, DIAKO Hospital Bremen, Germany

Lorenz H. Trümper

57 Hematology and Medical Oncology, University Medicine Goettingen, Germany

Gilles Salles

58 Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY, USA